182 related articles for article (PubMed ID: 20977797)
1. [Fish oil in prolonged parenteral nutrition in children--omega-3-fatty acids have a beneficial effect on the liver].
Strijbosch RA; van den Hoonaard TL; Olieman JF; Escher JC; Alwayn IP; Meijers-Ijsselstijn H
Ned Tijdschr Geneeskd; 2010; 154():A2003. PubMed ID: 20977797
[TBL] [Abstract][Full Text] [Related]
2. [Omega-3 fatty acids in parenteral nutrition: are they what makes the difference?].
Wanten G
Ned Tijdschr Geneeskd; 2010; 154():A2316. PubMed ID: 20977798
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
4. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
Burns DL; Gill BM
JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
[TBL] [Abstract][Full Text] [Related]
5. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
Fallon EM; Le HD; Puder M
Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
7. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
Xu Z; Li Y; Wang J; Wu B; Li J
Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
[TBL] [Abstract][Full Text] [Related]
8. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
9. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L
J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
[TBL] [Abstract][Full Text] [Related]
10. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
11. Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion.
Klein CJ; Havranek TG; Revenis ME; Hassanali Z; Scavo LM
Nutr Clin Pract; 2013 Feb; 28(1):87-94. PubMed ID: 23319354
[TBL] [Abstract][Full Text] [Related]
12. [Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition].
Giraldo Villa A; Henao Roldan C; García Loboguerrero F; Martínez Volkmar MI; Contreras Ramírez MM; Ruiz Navas P;
Nutr Hosp; 2014 Apr; 29(4):844-51. PubMed ID: 24679026
[TBL] [Abstract][Full Text] [Related]
13. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M
JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170
[TBL] [Abstract][Full Text] [Related]
14. Total parenteral nutrition in patients with short bowel syndrome.
Ekema G; Milianti S; Boroni G
Minerva Pediatr; 2009 Jun; 61(3):283-91. PubMed ID: 19461572
[TBL] [Abstract][Full Text] [Related]
15. Parenteral nutrition-associated liver injury and increased GRP94 expression prevented by ω-3 fish oil-based lipid emulsion supplementation.
Zhu X; Xiao Z; Chen X; Li Y; Zhang X; Xu Y; Feng X; Wang J
J Pediatr Gastroenterol Nutr; 2014 Dec; 59(6):708-13. PubMed ID: 25199039
[TBL] [Abstract][Full Text] [Related]
16. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
[TBL] [Abstract][Full Text] [Related]
17. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans.
Mayer K; Meyer S; Reinholz-Muhly M; Maus U; Merfels M; Lohmeyer J; Grimminger F; Seeger W
J Immunol; 2003 Nov; 171(9):4837-43. PubMed ID: 14568963
[TBL] [Abstract][Full Text] [Related]
18. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
Diamond IR; Sterescu A; Pencharz PB; Kim JH; Wales PW
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
[TBL] [Abstract][Full Text] [Related]
19. An exclusively based parenteral fish-oil emulsion reverses cholestasis.
Triana Junco M; García Vázquez N; Zozaya C; Ybarra Zabala M; Abrams S; García de Lorenzo A; Sáenz de Pipaón Marcos M
Nutr Hosp; 2014 Oct; 31(1):514-6. PubMed ID: 25561149
[TBL] [Abstract][Full Text] [Related]
20. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
Strang BJ; Reddix BA; Wolk RA
Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
